The aim was to update the 2009 European League against Rheumatism (EULAR)
recommendations for the treatment of systemic sclerosis (SSc), with attention to new therapeutic …

Background A phase 2 trial of tocilizumab showed preliminary evidence of efficacy in systemic
sclerosis. We assessed skin fibrosis and systemic sclerosis-associated interstitial lung …

The stereotype content model (SCM) proposes potentially universal principles of societal
stereotypes and their relation to social structure. Here, the SCM reveals theoretically grounded, …

Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis of the skin and
internal organs that leads to profound disability and premature death. To identify new SSc …

Introduction: Systemic sclerosis (SSc) is a complex autoimmune connective tissue disease
characterized by chronic and progressive tissue and organ fibrosis with broad patient-to-…

The Neuropsychiatric Inventory (NPI) is a validated clinical instrument for evaluating
psychopathology in dementia. The authors developed a brief questionnaire form of the NPI (NPI-Q), …

Objectives To determine the causes of death and risk factors in systemic sclerosis (SSc).
Methods Between 2000 and 2011, we examined the death certificates of all French patients …

Background Plasmacytoid dendritic cells have been implicated in the pathogenesis of
systemic sclerosis through mechanisms beyond the previously suggested production of type I …

Glial fibrillary acidic protein (GFAP) is the main astrocytic intermediate filament (IF). GFAP
splice isoforms show differential expression patterns in the human brain. GFAPδ is …

Systemic sclerosis, also known as scleroderma, is a rare and complex autoimmune
connective-tissue disease. Once considered an untreatable and unpredictable condition, research …